MOBILion secures $35 million from its latest Series B financing round
Date: 2020-08-19   Author: Pankaj Singh  Category: #news

MOBILion secures $35 million from its latest Series B financing round

MOBILion intends to expand the development of its product offerings for diagnostic applications and pharma QC

MOBILion Systems, a Pennsylvania-based biotechnology company that focuses on pioneering efficient, fast and high-resolution instrumentation for biomarker diagnostics and therapeutic development, has recently closed a $35 million Series B funding round led by aMoon. The funding round saw active participation from existing investors like IP Group, Agilent Technologies, Cultivation Capital and Hostplus.  

As per reports, MOBILion plans to utilize these funds to build a commercial team that would help it support the launch of the firm's first product built on patented ion mobility separations solution, dubbed Structures for Lossless Ion Manipulation (SLIM).  

SLIM technology efficiently and rapidly separates, analyzes and identifies the most crucial, clinically significant molecules that other devices fail to do. The technology facilitates earlier disease detection, enhanced diagnostic treatment and accuracy options, and offers reduced healthcare costs. Additionally, it delivers high-throughput analysis and unprecedented high-resolution for clinical researchers and the pharmaceutical industry.   

Speaking on the move, Melissa Sherman, Ph.D., CEO, MOBILion, said that the company is delighted to work with aMoon and all the existing community of investors that jointly share its vision to improve how healthcare facilities diagnose, treat and predict disease by revealing molecules that remaining instruments can’t detect. 

MOBILion is fueled with the positive feedback associated with its beta launch and validation of its initial product's abilities as established through published achievements of initial adopters and industry awards and recognitions. The financing round would augment its marketing and sales efforts as well as accelerate the development phase of second-generation equipment, added Sherman.  

As for Todd Sone, Partner, aMoon, both the companies have a shared vision to commercialize and develop a breakthrough solution that provides unparalleled speed and resolution. MOBILion comes as the newest addition in the company’s series of investments in the 'omics' field. The firm is looking forward to working with Melissa and her highly skilled team as they advance novel biomarker discovery and large molecule development.

Source Credit:

About Author

Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj

Post Recommendents

Global BIM Software Market Latest Trend, Growth, Size, Application & Forecast 2025
Author: Sachin Pashte

Market Study Report has recently added a report on BIM Software Market which provides a succinct analysis of the market size, revenue forecast, and the regional landscape of this industry. The report also highlights the major challenges and curren...

Chemical Indicators Market 2020 | Outlook, Growth By Top Companies, Regions, Types, Applications, Drivers, Trends & Forecasts by 2025
Author: Sachin Pashte

Market Study Report, LLC, has added a research study on ' Chemical Indicators market' which delivers a concise outline of the market share, market size, revenue estimation, geographical outlook and SWOT analysis of the business. The report...

Linear Slides Market Outlook, Strategies, Manufacturers, Countries, Type and Application, Global Forecast To 2025
Author: Sachin Pashte

Market Study Report, LLC recently added a report on ' Linear Slides market' that delivers a holistic view on industry valuations, market size, profit estimations, SWOT analysis and regional landscape of the market. In addition, the report ...